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Comparison of the effects of difenacoum and brodifacoum 
on the ultrastructure of rat liver cells
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We used transmission electron microscopy to examine the cytotoxic effects of the second-generation anticoagulant 
rodenticides difenacoum and brodifacoum on rat liver. A single dose of difenacoum or brodifacoum was administered to 
rats by gastric gavage and liver samples were taken after 24 h, four days or seven days. In the livers of rats treated with 
difenacoum for 24 h, hepatocytes typically showed increased numbers of lysosomes, as well as enlargement of both the 
perinuclear space and the cisternae of the rough endoplasmic reticulum (RER), while sinusoids were irregularly shaped 
and contained Kupffer cells. Similar irregularities occurred in brodifacoum-treated rats at the same time point, but 
additionally increased numbers of vacuoles, damaged mitochondrial cristae, and clumping of chromatin were observed 
in hepatocytes, and hemolysed erythrocytes were noted in the sinusoids. Comparable findings were made in each group 
of rats after four days. After seven days of difenacoum treatment, hepatocytes suffered loss of cytoplasmic material and 
mitochondrial shrinkage, while RER cisternae became discontinuous. In contrast, exposure to brodifacoum for seven 
days caused the formation of numerous vacuoles and lipid droplets, disordered mitochondrial morphology, chromatin 
clumping and invagination of the nuclear envelope in hepatocytes. Sinusoids in the livers of rodenticide-treated rats 
contained an accumulation of dense material, lipid droplets, cells with pycnotic nuclei and hemolysed erythrocytes. 
Overall, our results show that brodifacoum causes more severe effects in liver cells than difenacoum. Thus our microscopic 
data along with additional biochemical assays point to a severe effect of rodenticide on vertebrates.
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Difenacoum and brodifacoum are synthetic second-
generation anticoagulant rodenticides (SGARs) derived 
from coumarin. They are known to be more effective at 
targeting rats than indandione derivatives (1) and, compared 
to other SGARs, have good activity against the brown rat 
(Rattus norvegicus) and excellent activity against mice 
(2-6).
Difenacoum bait formulations against semi-wild and 
wild R. rattus (black rat) give excellent control in the field 
(7). Oral LD50 values for difenacoum are 1.8 mg kg
-1 for 
rats, 2.0 mg kg-1 for rabbits. The dermal dose of difenacoum 
in rodents is somewhat higher, >50 mg kg-1 for rats and 
rabbits (8). Difenacoum has been reported to act as a poison 
against both target (rodents) and non-target (e.g. human, 
dog, cat) animals (9-13). According to a research performed 
in France, accidental exposure to rodenticide is high in 
children aged 1-4, as well as in cats and dogs, with exposure 
rates of 41 % in children and 85 % in pet animals (12).
Brodifacoum has been widely used for the control of 
rodents since the mid-1970s (5, 14-18), and has a longer 
half-life in tissues than warfarin (19). The LD50 for 
brodifacoum is 1 mg kg-1 or less in mammals (20), and only 
a single dose is needed for a lethal effect on rodents (21). 
However, there are multiple reports of non-target activity. 
Thus, Dowding et al. (2) pointed out that brodifacoum 
poisoning resulted in significant mortality of non-target 
animals, including domestic cats, as well as wild rabbits 
and birds, in an operation to eradicate rodents on Motuihe 
Island, New Zealand. Presumed in utero brodifacoum 
toxicity has been reported in the livers of two neonatal 
puppies with haemorrhage (1, 22), and brodifacoum can 
cause decreased sperm concentration, as well as an increase 
in dead and abnormal spermatozoa, in the testes and 
epididymis of Mus musculus (23). Poisoning of raptor 
populations has also been reported; for example, 
brodifacoum was detected at concentrations ranging from 
0.001 to 0.927 mg kg-1 in the livers of three owls in western 
Canada (4). Clearly, SGARs are poisonous for both target 
and non-target animals, and there have been a number of 
studies on the cellular damage caused by these rodenticides. 
Transmission electron microscopy (TEM) showed that 
difenacoum perturbs organelle structure in rat liver cells, 
for example, causing nuclear shrinkage, proliferation of 
lipid droplets, and destruction of the endoplasmic reticulum 
(ER) and mitochondria (6). Binev et al. (24) used light 
microscopy to show that bromadiolone, another SGAR, 
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causes degeneration of liver, lung, and kidney cells in 
pheasants.
Although both difenacoum and brodifacoum are widely 
used rodenticides, there are no published comparisons of 
their cytotoxic effects on the liver cells of target animals. 
In this report, we describe the ultrastructural studies which 
show that, while both SGARs cause devastating damage to 




Adult male rats (Wistar albino, 7-9 weeks old, 190-
230 g body weight) were used in this study following the 
ethical approval from the Ankara University Ethics 
Committee. The animals were divided into seven groups 
(n=5 for each group) for SGAR (difenacoum and 
brodifacoum) treatments: a control (untreated) group, 24 h, 
four days, and seven days. Each animal was kept in a 
separate cage at room temperature with a photoperiod of 
12:12 h light–dark and 65 % humidity. Animals were 
quarantined for seven days before the experiments (14).
Experiments with difenacoum and brodifacoum
SGAR doses under the LD50 were applied to the samples 
in order to determine the chronic cytotoxic effects. Thus a 
single dose of difenacoum (0.8 mg kg-1) or brodifacoum 
(0.2 mg kg-1) dissolved in DMSO/polyethylene glycol 
(PEG)-400/water (0.02 mL/1 mL/1 mL) was orally 
administered by gastric gavage to each animal in the assay 
groups. A single dose (1 mL kg-1) of DMSO/PEG-400/water 
was given orally by gastric gavage to control group rats at 
the same time (21). All rats were fed standard laboratory 
diet and water during the experiment. Rodenticide-treated 
animals were killed by cervical dislocation after 24 h, four 
days, or seven days and liver tissues were obtained for 
examination by TEM. Control group rats were sacrificed 
after seven days (14).
Transmission electron microscopy
Tissue samples for TEM were immersed in 2.5 % 
glutaraldehyde buffered to pH 7.4 with 0.1 mmol L-1 sodium 
phosphate, and kept cold for 2 h. After rinsing three times 
in cold sodium phosphate buffer, the tissues were post-fixed 
in 1 % osmium tetroxide solution for 2 h at 4 ºC. Fixed 
tissues were dehydrated in a series of graded ethanols, 
placed into propylene oxide, and embedded in araldite (25). 
Ultrathin sections were stained with 2 % uranyl acetate and 
lead citrate and examined at 80 kV using a JEOL 100CX 
II (JEOL, Ltd. Tokyo-JAPAN) microscope in the Biology 
Department, Faculty of Science, Ankara University.
RESULTS
The rats exposed to rodenticides displayed behavioural 
disorders and external haemorrhage after 24 h of exposure, 
with mortality ensuing within seven days, accompanied by 
haemorrhage in the eyes, nose, and mouth. Morphological 
examination showed the livers of these rats to be discoloured 
and enlarged compared to those of control group rats.
Our results demonstrate that difenacoum and 
brodifacoum have destructive effects on the structure of 
liver cells, for example, causing marked alteration of 
organelle morphology. In control rats, TEM showed that 
hepatocytes contained a circular or oval-shaped nucleus 
with fine granular components and chromatin condensation 
of the nucleoplasm, regular-shaped rough endoplasmic 
reticulum (RER) and mitochondria, cytoplasmic granules, 
randomly located glycogen granules, and a homogeneous 
cytoplasm. The sinusoidal space in these animals appeared 
regular in shape and contained homogeneous separate fine 
granular material (Figure 1).
Figure 1 The liver of control group rats. Mitochondria (M), rough 
endoplasmic reticulum (double arrow), nucleus (N), nucleolus (n), 
glycogen (single arrow), sinusoid (S), erythrocytes (E). (1000 x)
In contrast, livers from rats treated with difenacoum for 
24 h showed structural changes such as damaged 
mitochondrial cristae and enlargement of both the RER 
cisternae and the perinuclear space (Figure 2). The 
hepatocyte cytoplasm showed vacuolisation, with many 
cisternae in the RER and clumping of chromatin in the 
nucleoplasm. The sinusoids were irregularly shaped and 
contained many Kupffer cells and disordered hepatocytes 
with hyalinisation of the mitochondrial matrix and fusion 
of mitochondrial membranes; there were also numerous 
sinusoid-proximal lysosomes in these cells (Figure 3). The 
presence of Kupffer cells in the sinusoid may indicate the 
degree of poisoning with difenacoum.
In rats exposed to difenacoum for four days, liver cells 
had a markedly different structure to those of the control 
group. A lot of lysosomes/autophagosomes, few glycogen 
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granules, enlarged mitochondria, and mitochondrial 
membrane fusion were observed. As an indication of the 
immune response, a plasma cell was observed in the 
sinusoid of four days difenacoum-treated rat liver (Figure 
4). In the case of brodifacoum treatment for four days, TEM 
also showed abnormal structure of the hepatocyte nucleus, 
such as invagination of the nuclear envelope, clumping of 
chromatin, and localisation of chromatin near the nuclear 
envelope. In the thin sections of the liver cells of these 
animals, the melting of mitochondrial cristae and lysosomes 
were again observed (Figure 5). Erythrocytes with disrupted 
cytoplasmic materials, Kupffer cells, and an accumulation 
of dense material were seen in the sinusoid. Hepatocytes 
around the sinusoid had an abundance of mitochondria with 
damaged cristae and lysosomes (Figure 6).
In rats treated with difenacoum administered for seven 
days, hepatocytes contained mitochondria of varying sizes, 
Figure 2 Enlarged cisternae of rough endoplasmic reticulum 
(double arrow) and nuclear envelope (single arrow), nucleus (N), 
nucleolus (n), and damaged cristae of mitochondria (m) of 24 h 
difenacoum-treated rat hepatocytes. (7200 x)
Figure 3 Sinusoid (S) filled with Kupffer cells (single arrow) and 
hepatocyte contained many lysosomes (L) and mitochondrial 
cristae damaged (bold arrow) ın the 24 h brodifacoum-treated rat 
livers. (2900 x)
Figure 4 Four days difenacoum-treated rat liver with deformed 
hepatocytes and plasma cell in the sinusoid. Lysosome (L), plasma 
cell (PL), rough endoplasmic reticulum (RER), mitochondria (m), 
mitochondrial membrane fusion (single arrow). (5800 x)
Figure 5 Damaged cristae of mitochondria (m), lysosome (L), 
invagination of nuclear envelope (double arrow), localisation of 
chromatin material (single arrow) in the four days brodifacoum-
treated rat hepatocytes. (5800 x)
from small to large, RER with discontinuous cisternae, few 
glycogen granules, and focal necrotic areas (Figure 7). 
Additionally, structural irregularities were apparent in the 
enlarged sinusoid, an accumulation of dense material, loss 
of cytoplasmic material in Kupffer cells, as well as 
hepatocytes (Figure 8). After seven days, the livers of 
brodifacoum-treated rats contained hepatocytes with 
invagination of the nuclear envelope, chromatin clumping, 
structural residues in lysosomes, damaged mitochondrial 
cristae, mitochondrial membrane fusion, Kupffer cells, and 
cellular residues in the enlarged sinusoid. Further signs of 
severe liver damage in these rats included the variation of 
the size of mitochondria, as well as damaged cristae and 
membrane fusion in mitochondria, lipid droplets and 
lysosomes in hepatocytes. Hepatocytes were thoroughly 
corrupted ultrastructurally, for example, containing 
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numerous lipid droplets, damaged and misshaped 
mitochondria that were often fused to each other, and 
necrotic nuclear material in their cytoplasm (Figure 9).
DISCUSSION
In this study, we confirmed that the SGARs brodifacoum 
and difenacoum have different harmful effects on rat liver 
cells such as damaged mitochondrial cristae, discontinuous 
RER cisternae, many lysosomes, lipid droplets, and nuclear 
abnormalities in the hepatocytes. Littin et al. (15) reported 
that Norway rats and possums displayed behavioural 
disorders, pathologic changes, and even death after 
poisoning with brodifacoum. When dead animals were 
autopsied, internal bleeding was evident alongside other 
cytotoxic effects. These findings are consistent with our 
results and are also reported in previous studies by Lechevin 
and Vigie (26). We observed that, 24 h after receiving 
brodifacoum, rats showed behavioural disorders, while 
eyes, mouth, and nose bleeding occurred around the fourth 
day. By the sixth day, most animals were dead. It was also 
noted that the animals monitored showed internal bleeding 
and developed necrosis in their livers due to the anticoagulant 
poison. Revathi and Yogananda (27) gave bromadiolone to 
mice (Mus musculus) orally and observed an enlargement 
of their livers, and cytoplasmic vacuolisation in hepatocytes, 
as well as necrosis and accumulation of toxic debris. These 
findings are consistent with our own, particularly the 
increase in vacuoles and necrosis on the seventh day. 
According to DuVall et al. (28), reporting a study performed 
in 1986-1987, some cats and dogs poisoned by a rodenticide 
showed swollen hepatocyte vacuoles and an accumulation 
of substances in sinusoids, together with subcutaneous 
bleeding. This fits with our findings that, after four and 
seven days of brodifacoum treatment, rats increased 
vacuolisation in hepatocytes and haemolysed erythrocytes.
Figure 7 Hepatocyte degeneration of seven days difenacoum-
treated rat livers. Mitochondria (m), focal necrotic area (star), 
discontinuous RER cisternae (bold arrow), a few glycogen grains 
(single arrow). (10000 x)
Figure 8 Liver of seven days difenacoum-treated rat liver. 
Erythrocyte (E), accumulation of electron dense material (star), 
Kupffer cell (K), loss of cytoplasmic area in the hepatocytes (bold 
arrow), mitochondria (single arrow), sinusoid (S). (5800 x)
Figure 6 Liver cells of four days brodifacoum-treated rats. 
Erythrocyte (E), Kupffer cell (K), mitochondria with damaged cristae 
(m), cellular residue (star), lysosome (single arrow). (5800 x)
Dowding et al. (2) reported an average brodifacoum 
level of 0.84 µg g-1 in the livers of 29 dead individuals 
belonging to ten bird species. Brodifacoum residues were 
also detected in the livers of target and non-target animals 
by  h igh  per formance  l iqu id  chromatography 
(2, 3, 13, 22, 29). In our study, the ultrastructure of the liver 
of rats given a dose of brodifacoum was severely affected, 
and these effects were particularly marked after the fourth 
and seventh days. When we examined the liver cells of 
difenacoum-treated rats by TEM, the primary morphological 
change was a loss of cytoplasmic material. Additionally, 
we observed accumulation of substances in the sinusoids. 
The consequences of accidental exposure to anticoagulant 
rodenticides in humans and non-target animals include 
physiological defects such as the inhibition of the vitamin 
K cycle, anaemia, hypoproteinaemia, hypalbuminaemia, 
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hyperglycaemia, and bilirubinaemia; other adverse effects 
include an increase in active coagulation time, oedema in 
the lungs, tachycardia, haemorrhage, skin hyperaemia, and 
nose, ear, and vagina bleeding (18). Difenacoum-treated 
rats also showed nose and ear bleeding after four and seven 
days of treatment. Exposure to another SGAR, bromadiolone, 
led to multiple necrotic areas in the liver, hyperplasia of 
bile ducts, strong hyperaemia and haemorrhage, and 
siderocytes in lung parenchyma, vacuolisation of the 
cytoplasm with karyolysis, and karyopyknosis of tubular 
epithelial cells in the pheasant kidney (24). Similar findings 
were observed in our anticoagulant-treated rats after four 
and seven days in respect of the vacuolisation and karyolysis 
of hepatocyte cytoplasm and the presence of haemolysed 
erythrocytes in the sinusoid.
An electron microscopy study in rats showed that 
difenacoum, at doses of 0.25 mg kg-1 and 0.5 mg kg-1, was 
highly cytotoxic and had severe effects on the liver 
ultrastructure, including the compression of sinusoids and 
enlargement of Kupffer cells; in hepatocytes, necrotic 
nuclei, cytoplasmic vacuolisation, lipid droplets, disrupted 
RER cisternae and mitochondria were observed (26). This 
is reminiscent of our results on liver organelles after rats 
were treated with a 0.8 mg kg-1 dose of difenacoum.
CONCLUDING REMARKS
As a result, when the effect of the two rodenticides was 
compared across treatment groups, brodifacoum was found 
to cause greater damage to cell organelles than difenacoum. 
The most marked differences were an increased number of 
lipid droplets and lysosomes, a necrotic nucleus, 
discontinuous RER cisternae, and mitochondrial deformity 
after exposure to brodifacoum. These electron microscopic 
and morphological observations will provide the basis for 
Figure 9 Ultrastructural deformation in the hepatocytes of seven 
days brodifacoum-treated rats. Chromatin clumping in the nucleus 
(single arrow) and invagination of nuclear envelope (bold arrow), 
lipid droplets (Lp), autophagosome (bold arrow), damaged cristae 
of mitochondria (m), cellular residues (star), sinusoid (S). (7200 x)
further research on the cytotoxic effects of anticoagulant 
rodenticides.
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Usporedba učinaka difenakuma i brodifakuma na ultrastrukturu jetara štakora
Transmisijskim elektronskim mikroskopom ispitivali smo citotoksične učinke druge generacije antikoagulacijskih 
rodenticida difenakuma i brodifakuma na jetra štakora. Štakori su dobili jednu dozu difenakuma ili brodifakuma gavažom, 
a uzorci jetara uzeti su nakon 24 sata te nakon četiri ili sedam dana. U hepatocitima štakora kojima je dan difenakum 
tijekom 24 sata uočen je povećan broj lizosoma te povećanje perinuklearnoga prostora i cisterne hrapavog endoplazmatskog 
retikuluma (eng. Rough Endoplasmic Reticulum - RER), a sinusoidi su bili nepravilnog oblika i sadržavali su Kupfferove 
stanice. Slične su nepravilnosti uočene i u štakora koji su tretirani brodifakumom u istom razdoblju, ali su uz to primijećeni 
i povećan broj vakuola, oštećene mitohondrijske kriste i nakupljanje kromatina u hepatocitima te hemolizirani eritrociti 
u sinusoidima. Nakon četiri dana nalazi su bili usporedivi u svim skupinama štakora. Nakon sedam dana tretiranja 
difenakumom, u hepatocitima je uočen gubitak citoplazmatskog materijala i smanjenje mitohondrija, a cisterne RER-a 
postale su isprekidane. Izloženost brodifakumu tijekom sedam dana uzrokovala je stvaranje različitih vakuola i lipidnih 
kapljica, poremećaj mitohondrijske morfologije, nakupljanje kromatina i invaginaciju nuklearne omotnice u hepatocitima. 
U sinusoidima jetara štakora koji su tretirani rodenticidom primijećeno je nakupljanje gustog materijala, lipidnih kapljica, 
stanica s piknotičkim nukleusima i hemoliziranih eritrocita. Općenito, naši rezultati upućuju na to da brodifakum uzrokuje 
ozbiljnije učinke u jetrenim stanicama od difenakuma. Naši podaci dobiveni mikroskopskim ispitivanjem i ostalim 
biokemijskim testovima govore u prilog štetnom učinku rodenticida na kralježnjake.
KLJUČNE RIJEČI: hepatocit, sinusoid; hrapavi endoplazmatski retikulum; transmisijski elektronski mikroskop; vakuola
